Form D · Pharmaceuticals
EpiVario Inc.
Philadelphia, PA · CIK 0001753351
Offering snapshot reported Oct 13, 2026 · SEC filing
- Reported sold
- $185K Offering amount: $500K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Sep 25, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2026 | Initial | $185,000 | No comparison | 9 | SEC filing |
| Jan 16, 2024 | Initial | $125,000 | No comparison | 3 | SEC filing |
| Sep 12, 2022 | Initial | $135,000 | No comparison | 3 | SEC filing |
| Aug 3, 2021 | Initial | $233,000 | No comparison | Not reported | SEC filing |
| Mar 13, 2020 | Amendment | $599,500 | $60,000vs Jun 10, 2019 | 23 | SEC filing |
| Jun 10, 2019 | Amendment | $539,500 | $94,000vs Dec 12, 2018 | 23 | SEC filing |
| Dec 12, 2018 | Amendment | $445,500 | $240,500vs Sep 21, 2018 | 22 | SEC filing |
| Sep 21, 2018 | Initial | $205,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-600835
Source: Form D, filed Oct 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Cashman | Director |
| Yi Yen Chen | Director |
| Michael Dishowitz | Director |
| Thomas Kim | Director, Executive |
| Philipp Mews | Director |
| Eric Schultenover | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3401 Grays Ferry Avenue Building 176
Philadelphia, PA, 19146
Philadelphia, PA, 19146